Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update" is generating significant coverage in the Business category, with 8 articles from 7 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Benzinga, KVUE, Devdiscourse and Fierce Biotech. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 2h ago.
Quick answers
Why is "Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides" trending?
Because 7 independent news sources published 8 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (8)
- Why Is Capricor Therapeutics Stock Soaring Today? Benzinga · 1d ago
- Capricor: Q2 Earnings Snapshot KVUE · 1d ago
- Capricor's Stock Surge, Congo's Ebola Outbreak, and More in Health News Devdiscourse · 1d ago
- This Capricor Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday Benzinga · 1d ago
- Capricor soars on plan to amend DMD filing after adcomm setback Fierce Biotech · 1d ago
- Capricor shares soar as potential FDA lifeline revives Duchenne drug hopes Reuters · 1d ago
- CAPR Stock Explodes Premarket: Cantor Flips Bullish, Sees 278% Upside On Deramiocel FDA Path Yahoo Finance · 1d ago
- Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Capricor Therapeutics, Inc. · 1d ago
Topics
Related trends
Nationals Moving CJ Abrams To Second Base
5 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.
Second train derails in England in less than 24 hours amid record heatwave
1 news sources are covering this World story right now — PULSE is tracking how fast it spreads.
Reports: Panthers to sign tight end Darren Waller
1 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.
Cerebras Systems Reports Solid Earnings. The Stock Is Plunging.
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
A 10-Second Treatment Can Stop Tooth Decay in Kids Without Drilling
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Supermicro Announces Fourth Quarter and Full Fiscal Year 2026 Financial Results
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.